Table 2.
Demographic, clinic and laboratory features of diabetic patients according to EAT groups
| Parameters | EAT < 4.53 (n = 78) | EAT ≥ 4.53 (n = 78) | P value |
|---|---|---|---|
| Age (years) |
52.80 ± 9.39 |
54.44 ± 9.27 |
0.273 |
| Female/Male |
46/32 |
41/37 |
0.519 |
| BMI (kg/m2) |
30.18 ± 6.00 |
32.24 ± 5.59 |
0.028 |
| Waist circumference |
100.30 ± 11.36 |
106.19 ± 10.49 |
0.001 |
| HbA1c (%) |
9.12 ± 2.55 |
9.16 ± 2.35 |
0.922 |
| Disease duration (months) |
82.62 ± 72.75 |
94.00 ± 77.92 |
0.347 |
| SBP (mmHg) |
135.77 ± 26.57 |
135.83 ± 27.54 |
0.988 |
| DBP (mmHg) |
73.78 ± 9.58 |
75.19 ± 13.05 |
0.443 |
| Total cholesterol (mmol/L) |
5.46 ± 1.37 |
5.53 ± 1.35 |
0.731 |
| Triglyceride (mmol/L) |
2.12 ± 1.18 |
2.57 ± 1.83 |
0.068 |
| LDL - cholesterol (mmol/L) |
3.46 ± 1.15 |
3.33 ± 1.09 |
0.468 |
| HDL - cholesterol (mmol/L) |
1.16 ± 0.22 |
1.04 ± 0.24 |
0.002 |
| AIP |
0.21 ± 0.28 |
0.33 ± 0.30 |
0.010 |
| eGFR (mL/min) |
115.51 ± 38.70 |
118.00 ± 43.04 |
0.705 |
| Creatinin (mg/dL) |
0.78 ± 0.25 |
0.86 ± 0.45 |
0.145 |
| EAT (mm) |
3.52 ± 0.75 |
5.80 ± 1.37 |
<0.001 |
| NLR |
1.73 ± 0.69 |
2.08 ± 0.90 |
0.007 |
| PLR |
109.14 ± 38.06 |
124.20 ± 43.85 |
0.023 |
| Uric Acid (mg/dL) | 4.62 ± 1.42 | 4.74 ± 1.58 | 0.628 |
AIP; Atherogenic index of plasma, BMI; body mass index, EAT; epicardial adipose tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-to-lymphocyte ratio.